Joshua Jacobs to Survival Analysis
This is a "connection" page, showing publications Joshua Jacobs has written about Survival Analysis.
Connection Strength
0.089
-
Long-term Safety and Efficacy of Reslizumab in Patients with Eosinophilic Asthma. J Allergy Clin Immunol Pract. 2017 Nov - Dec; 5(6):1572-1581.e3.
Score: 0.037
-
The progression of patellofemoral arthrosis after medial unicompartmental replacement: results at 11 to 15 years. Clin Orthop Relat Res. 2004 Nov; (428):92-9.
Score: 0.015
-
Unicompartmental knee arthroplasty. Clinical experience at 6- to 10-year followup. Clin Orthop Relat Res. 1999 Oct; (367):50-60.
Score: 0.011
-
The fate of well fixed cemented femoral components left in place at the time of revision of the acetabular component. J Bone Joint Surg Am. 1997 May; 79(5):701-6.
Score: 0.009
-
Primary total hip arthroplasty with a porous-coated acetabular component. Seven-to-ten-year results. J Bone Joint Surg Am. 1997 Feb; 79(2):169-76.
Score: 0.009
-
Revision total hip arthroplasty without cement: subsidence of proximally porous-coated femoral components. J Bone Joint Surg Am. 1995 Aug; 77(8):1217-26.
Score: 0.008